Damora Therapeutics Inc Com (New) (DMRA:NASDAQ) closed at $21.53 on October 21, 2026, up 4.16% on the day. The stock trades 43.8% below its 52-week high of $38.33 and 334.9% above its 52-week low of $4.95. Over the past year, it gained 159.7%. Damora Therapeutics Inc Com (New) is part of the Health Care sector.
In 252 trading sessions since October 21, 2025, DMRA closed higher on 118 days (47%). Its best day was November 10, 2025 (+248.48%) and its worst was December 30, 2025 (-24.65%). The stock moved 10% or more in a single session 29 times. It opened at least 5% above the previous day's high 1 time.
Damora Therapeutics is an innovative biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. We are advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is significant medical need for disease-modifying treatments. With multiple programs with best-in-class potential on track to enter clinical development in 2026, our goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes.
Find more stocks like DMRA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.